PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells.

Front Immunol · 2017 · PMC5439058 · PMID 28588576

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a minor significanceno p-value reported

We have observed that coblockade of the putative coinhibitor CD160 did not enhance T cell responses, which could be explained by a minor significance of CD160 inhibition in this setting, but also by reduced costimulation via HVEM under conditions where two of its ligands are blocked.

also in 35 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.